351
Participants
Start Date
November 1, 2019
Primary Completion Date
July 26, 2021
Study Completion Date
October 20, 2021
ASP1128
Intravenous Infusion
Placebo
Intravenous Infusion
Delmarva Heart, LLC, Salisbury
WVU Heart and Vascular Institute, Morgantown
Moses H. Cone Memorial Hospital, Greensboro
Duke University Medical Center, Durham
Shands Hospital, Gainesville
Florida Hospital Pepin Heart Institute, Tampa
Morton Plant Hospital, Clearwater
Health Park Medical Center, Fort Myers
Heart Center Research, LLC, Huntsville
Vanderbilt University, Nashville
Baptist Medical Center, Jackson
ProMedica Toledo Hospital, Toledo
Fairview Hospital - Cleveland Clinic, Cleveland
IU Health - Methodist, Indianapolis
St. Vincent Heart Center, Indianapolis
Luthern Medical Group, Fort Wayne
Indiana University Health Ball Memorial Hospital, Muncie
Ascension Genesys Hospital, Grand Blanc
Mid Michigan Medical Center, Midland
MercyOne Iowa Heart Center, Des Moines
Minneapolis Heart Institute, Minneapolis
Southern Illinois University, Springfield
St. Luke's Hospital of Kansas City, Kansas City
Baylor Scott & White Heart Hospital, Plano
University of Texas Health Science Center, San Antonio
Sarver Heart Center, Tucson
Lourdes Cardiology Services, Voorhees Township
Lead Sponsor
Astellas Pharma Inc
INDUSTRY